Drugs / recombinant soluble human CD4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002004 | — | HIV infectious disease | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant soluble human CD4 | “recombinant soluble human CD4 (rCD4) therapy” NCT00002004 ↗ |
| Known as | rCD4 | “recombinant soluble human CD4 (rCD4) therapy” NCT00002004 ↗ |
| Known as | Recombinant CD4 | “Recombinant CD4 (rCD4)” NCT00002004 ↗ |